~~<i id='BE02652B17'><strike id='BE02652B17'><tt id='BE02652B17'><pre id='BE02652B17'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：Wikipedia 2025-09-06 06:16:21 - browse：17

Elite athletes really are different from you and me. Or, at least their gut microbes are.

Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： My superpower is killing ticks

hotspot

focus

leisure time

entertainment

knowledge

RubyWallauforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

WSS

The Harvard botanist who searched for psychedelics in the Amazon

'Ancient DNA,' 23andMe reveal African American ancestries

Attacks on the drug industry will lead to fewer breakthroughs

TytoCare raises $49 million to build out AI

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

The Harvard botanist who searched for psychedelics in the Amazon

hotspot

leisure time

hotspot

Alkermes shareholders re

The drug industry sees a key ally in the Senate prevail

Peter Hotez and the public health issue of online harassment

Medicare inequities exacerbate Puerto Rico’s health disparities

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Supreme Court strikes down use of affirmative action

Dario to buy mental health app maker Twill in cash and stock deal

23andMe had bad news about my health. I wish a person had delivered it

New documents shed light on MD Anderson Cancer Institute feud

focus

R1 RCM gets $5.8 billion buyout offer from private equity firm

STAT readers on older presidents, polypills, Medicare, and more

Dario to buy mental health app maker Twill in cash and stock deal

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Stem cell clinics for heart failure: buyer be wary

White House drug shortage group privately met with industry

leisure time

entertainment

entertainment

knowledge